Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Michele Pellegrini"'
Autor:
Marzia Monica Giuliani, Alessia Biolchi, Pavitra Keshavan, Maria Moriondo, Sara Tomei, Laura Santini, Elena Mori, Alessandro Brozzi, Margherita Bodini, Francesco Nieddu, Silvia Ricci, Thembile Mzolo, Marco Costantini, Chiara Azzari, Michele Pellegrini
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 5, Pp 1442-1449 (2021)
An increase in invasive meningococcal disease (IMD) incidence was observed in Tuscany in 2015/2016, mainly due to hypervirulent clonal complex (cc) 11 strains. In a post-hoc analysis, we assessed bactericidal activity of antibodies in sera from child
Externí odkaz:
https://doaj.org/article/3b3ca1d0c02a45ae9c30a2bffec4f220
Autor:
Javier Díez-Domingo, Juan Carlos Tinoco, Airi Poder, Ener Cagri Dinleyici, Haylene Nell, Ignacio Salamanca de la Cueva, Tolga Ince, Edson Duarte Moreira, Khatija Ahmed, Kleber Luz, Yulia Kovshirina, Carlos Eduardo Medina Pech, Tauseefullah Akhund, Valerio Romolini, Marco Costantini, Thembile Mzolo, Barry Kunnel, Isabelle Lechevin, Marianna Aggravi, Paola Tiberi, K Narendran, Juan-Antonio García-Martínez, Venere Basile, Elena Fragapane, Maria Lattanzi, Michele Pellegrini
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
A fully liquid MenACWY-CRM vaccine presentation has been developed, modifying the meningococcal serogroup A (MenA) component from lyophilized to liquid. The safety and immunogenicity of the liquid presentation at the end of the intended shelf-life (a
Externí odkaz:
https://doaj.org/article/a357138d04704362afe0b14875033bb6
Autor:
Byung Wook Yoo, Hye Lim Jung, Yoon Seob Byeon, Dong Ki Han, Nak Yeong Jeong, Carlo Curina, Luca Moraschini, Sung Jin Kim, Chiranjiwi Bhusal, Michele Pellegrini, Yan Miao
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1260-1267 (2020)
The quadrivalent meningococcal conjugate vaccine MenACWY-CRM is approved in the Republic of Korea for use in individuals from 2 months of age. This single-arm, open-label, observational, multicenter, post-marketing study (NCT01766206) assessed the sa
Externí odkaz:
https://doaj.org/article/c47b928758774878bd4e7be26580e4f6
Autor:
Cinzia Correale, Chiara Falamesca, Ilaria Tondo, Marta Borgi, Francesca Cirulli, Mauro Truglio, Oriana Papa, Laura Vagnoli, Cinzia Arzilli, Cristina Venturino, Michele Pellegrini, Valentina Manfredi, Rossella Sterpone, Teresa Grimaldi Capitello, Simonetta Gentile, Simona Cappelletti
Publikováno v:
Children, Vol 9, Iss 8, p 1156 (2022)
COVID-19 is continuing to spread around the world, having a direct impact on people’s daily lives and health. Although the knowledge of the impact of the COVID-19 pandemic on mental health in the general population is now well established, there is
Externí odkaz:
https://doaj.org/article/674377bae7264defbe71a3058e9380f4
Publikováno v:
Infectious Diseases and Therapy, Vol 8, Iss 3, Pp 335-341 (2019)
Abstract Introduction Vaccines against human papillomavirus (HPV), tetanus, diphtheria, pertussis (Tdap) and Neisseria meningitidis are widely recommended in adolescents. A phase-4 observer-blind study was performed to investigate the impact of conco
Externí odkaz:
https://doaj.org/article/638d48cbe057412d8368c14836e9256b
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 10, Pp 865-880 (2018)
Introduction: Menveo, quadrivalent meningococcal ACWY-CRM conjugate vaccine, was first licensed in 2010 in the United States and has a long track record of immunogenicity and safety in all age groups, including infants from 2 months of age. Areas cov
Externí odkaz:
https://doaj.org/article/069b4722322c44caaffe05c56048aa1b
Autor:
Phirangkul Kerdpanich, Pornthep Chanthavanich, Mari Rose De Los Reyes, Jodor Lim, Delia Yu, Ma Cecilia Ama, Zenaida Mojares, Daniela Casula, Ashwani Kumar Arora, Michele Pellegrini
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 12, Iss 6, p e0006340 (2018)
This phase III clinical trial compared the immunogenicity and safety of a purified chick-embryo cell rabies vaccine (PCECV) administered according to a shortened post-exposure prophylaxis (PEP) 4-site/1-week intradermal regimen, compared with the cur
Externí odkaz:
https://doaj.org/article/5a4dc1cee2d24b84a83bdd13b14f40ab
Publikováno v:
Acque Sotterranee, Vol 1, Iss 2 (2012)
Implementation of groundwater flow and transport numerical models is generally a challenge, time-consuming and financially-demanding task, in charge to specialized modelers and consulting firms. At a later stage, within clearly stated limits of appli
Externí odkaz:
https://doaj.org/article/74ba12af9e8d40a3ad1bff2098c8a690
Autor:
Vincenzo Baldo, Tatjana Baldovin, Michele Pellegrini, Gabriele Angiolelli, Silvia Majori, Annarosa Floreani, Marta Cecilia Busana, Chiara Bertoncello, Renzo Trivello
Publikováno v:
Clinical and Developmental Immunology, Vol 2010 (2010)
We studied whether MF59-adjuvanted influenza vaccine improves immunity against drifted influenza strains in institutionalised elderly with underling chronic health conditions. Sera from a randomized study, comparing MF59-adjuvanted (Sub/MF59, n=72),
Externí odkaz:
https://doaj.org/article/cdb037156364461fb4af2d23066a39e3
Publikováno v:
Pharmaceutical Statistics. 22:570-576